Titlebook: Clinical Cancer Medicine; Treatment Tactics Jacob J. Lokich Book 1980 G.K. Hall & Co. 1980 cancer

一個希拉里

書目名稱Clinical Cancer Medicine影響因子(影響力)




書目名稱Clinical Cancer Medicine影響因子(影響力)學(xué)科排名




書目名稱Clinical Cancer Medicine網(wǎng)絡(luò)公開度




書目名稱Clinical Cancer Medicine網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Clinical Cancer Medicine被引頻次




書目名稱Clinical Cancer Medicine被引頻次學(xué)科排名




書目名稱Clinical Cancer Medicine年度引用




書目名稱Clinical Cancer Medicine年度引用學(xué)科排名




書目名稱Clinical Cancer Medicine讀者反饋




書目名稱Clinical Cancer Medicine讀者反饋學(xué)科排名

銼屑

AVANT

持續(xù)

Hematologic Complications of Malignancy. Primary hematologic malignancies represent a relatively small proportion of the hematologic manifestations of neoplastic disease. On the other hand, secondary hematologic manifestations of malignant disease are exceedingly common.

COMMA

Management of Cancer Painn is relatively uncommon, and resistance to analgesic therapy is rare. Osier reviewed an extensive group of patients with terminal cancer and found that less than 10 percent required analgesia in the preterminal phase of the disease.

桶去微染

https://doi.org/10.1007/978-3-031-59888-3been, by and large, one of nihilism. Such an approach has been based on the assumption that the cancer patient will inevitably die and that the acute complication may obviate a long period of suffering. Consequently, it is common for the patient with cerebral metastases, for example, to be allowed t

桶去微染

https://doi.org/10.1007/978-3-031-59888-3 a pathologic process within the mediastinum and is considered an oncologic emergency because of the acute cerebral syndrome that results from venous obstruction and increased intracerebral pressure. If left untreated, venous obstruction in the upper thoracic cavity can progress to stasis of blood f

Entreaty

H. Saafi,M. A. Laribi,S. Zeghloulgnant neoplasms. With some tumor types, cardiac metastases may be present in over 60 percent of patients at postmortem examination. The most common tumors involving the heart are bronchogenic carcinoma by direct contiguous involvement and breast cancer by hematogenous dissemination (Table 3.1). Only

主動

陳列